Abstract
The objectives of this study were 1) to pursue the question of clozapine's striatal D2 occupancy in relation to its clinical effectiveness; 2) to investigate the relation between schizophrenic symptoms, clozapine blood levels, and estimated D2 occupancy during clinically stable and unstable conditions; and 3) to examine long-term stability in D2 occupancy. Specific binding of the D2 radioligand [123I]benzamide ([123I]IBZM) was studied with single photon emission computed tomography in 13 patients with schizophrenia when they were clinically stable during chronic clozapine treatment, after clozapine dose reduction of > or = 50%, and in a subgroup (N = 7) after restabilization on clozapine regimens. Clozapine's estimated D2 occupancy was based on comparison with values from drug-free normal subjects. A wide range of estimated D2 occupancies (18% to > or = 80%) were associated with sustained, favorable response to clozapine without correlation with residual symptoms. Clozapine blood levels were negatively related to [123I]IBZM specific binding. Acute dose reduction was associated with predicted worsening in positive and negative symptoms and increases in [123I]IBZM specific binding. Independent of clozapine blood level, patients w...Continue Reading
Citations
Sep 1, 2001·Psychiatry Research·M BernardoM Salamero
Jan 2, 2003·Annals of Nuclear Medicine·W Gordon Frankle, Marc Laruelle
Dec 8, 2010·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Farhat BatoolDarakhshan Jabeen Haleem
Apr 1, 2015·Journal of the Chinese Medical Association : JCMA·Chen-Chia LanYing-Sheue Chen
Jan 12, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Anissa Abi-Dargham, Marc Laruelle
Apr 29, 1998·The Psychiatric Clinics of North America·R J McClureJ W Pettegrew
Feb 24, 2009·NeuroImage·Ana M CatafauUNKNOWN Barcelona Clinical Imaging in Psychiatry Group
Feb 23, 2010·Biological Psychiatry·Thomas W WeickertDaniel R Weinberger
Jul 20, 2011·Journal of Psychopharmacology·Marise MachielsenInez Myin-Germeys
Feb 18, 2005·Psychopharmacology·Carmen Chung, Gary Remington
Mar 1, 2008·Journal of Psychopharmacology·A M CatafauUNKNOWN Barcelona Clinical Imaging in Psychiatry Group
Sep 15, 2004·Psychopharmacology·Vicente MolinaTomás Palomo
Oct 1, 2018·Reviews in the Neurosciences·Susanne NikolausHans-Wilhelm Müller
Dec 5, 2000·Behavioural Pharmacology·R D OadesB W Müller
Sep 2, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Marie-Bernadette AssiéAdrian Newman-Tancredi
Jun 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas J RaedlerDaniel R Weinberger
Jul 17, 2001·Nuclear Medicine Communications·L S Pilowsky
Feb 4, 2014·Reviews in the Neurosciences·Susanne NikolausHans-Wilhelm Müller
Jun 8, 2011·Pharmaceutical Research·Martin JohnsonJohannes H Proost
Feb 19, 2013·Psychopharmacology·Takefumi SuzukiDavid Mamo
Dec 5, 2002·Learning & Memory·Thomas W WeickertTerry E Goldberg